Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Van Braeckel

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|September 13, 2025
Physical Activity and Physical Function One Year After Hospital Discharge for COVID-19Eva Arents, Fien Hermans, Lies Glorie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2023
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standardHelmut J F Salzer, Maja Reimann, Carolin Oertel, et al.
Therapeutic Advances in Respiratory Disease|September 20, 2021
The short-term effects of ORKAMBI (lumacaftor/ivacaftor) on regional and distal lung structures using functional respiratory imagingEline Lauwers, Dennis Belmans, Benjamin Mignot, et al.
Perfusion|August 15, 2022
Video-assisted thoracic surgery in critically ill COVID-19 patients on venovenous extracorporeal membrane oxygenationBert Zwaenepoel, Korneel Vandewiele, Harlinde Peperstraete, et al.
BMC Microbiology|January 23, 2021
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCRTania Desmet, Peter De Paepe, Jerina Boelens, et al.
Respiratory Research|October 12, 2024
Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitroEllen Goeteyn, Steven L Taylor, Alison Dicker, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patientsKatrien Forier, Virginie Van Heck, Mieke Carlier, et al.
Biofilm|July 8, 2024
Antibiofilm activity of <i>Prevotella</i> species from the cystic fibrosis lung microbiota against <i>Pseudomonas aeruginosa</i>Lucia Grassi, Kyle L Asfahl, Sara Van den Bossche, et al.
Microbiology Spectrum|November 20, 2023
Pooling isolates to address the diversity in antimicrobial susceptibility of <i>Pseudomonas aeruginosa</i> in cystic fibrosisSara Van den Bossche, Emmanuel Abatih, Lucia Grassi, et al.
Virulence|May 12, 2026
Identification of DksA as a novel pro-inflammatory mediator of <i>Pseudomonas aeruginosa</i> under conditions mimicking chronic cystic fibrosis lung infectionMerel Wauters, Laura Bollé, Gilles De Meester, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|September 13, 2025
Physical Activity and Physical Function One Year After Hospital Discharge for COVID-19Eva Arents, Fien Hermans, Lies Glorie, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2023
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standardHelmut J F Salzer, Maja Reimann, Carolin Oertel, et al.
Therapeutic Advances in Respiratory Disease|September 20, 2021
The short-term effects of ORKAMBI (lumacaftor/ivacaftor) on regional and distal lung structures using functional respiratory imagingEline Lauwers, Dennis Belmans, Benjamin Mignot, et al.
Perfusion|August 15, 2022
Video-assisted thoracic surgery in critically ill COVID-19 patients on venovenous extracorporeal membrane oxygenationBert Zwaenepoel, Korneel Vandewiele, Harlinde Peperstraete, et al.
BMC Microbiology|January 23, 2021
Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCRTania Desmet, Peter De Paepe, Jerina Boelens, et al.
Respiratory Research|October 12, 2024
Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitroEllen Goeteyn, Steven L Taylor, Alison Dicker, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patientsKatrien Forier, Virginie Van Heck, Mieke Carlier, et al.
Biofilm|July 8, 2024
Antibiofilm activity of <i>Prevotella</i> species from the cystic fibrosis lung microbiota against <i>Pseudomonas aeruginosa</i>Lucia Grassi, Kyle L Asfahl, Sara Van den Bossche, et al.
Microbiology Spectrum|November 20, 2023
Pooling isolates to address the diversity in antimicrobial susceptibility of <i>Pseudomonas aeruginosa</i> in cystic fibrosisSara Van den Bossche, Emmanuel Abatih, Lucia Grassi, et al.
Virulence|May 12, 2026
Identification of DksA as a novel pro-inflammatory mediator of <i>Pseudomonas aeruginosa</i> under conditions mimicking chronic cystic fibrosis lung infectionMerel Wauters, Laura Bollé, Gilles De Meester, et al.
Pageof 8